
Neoadjuvant Chemo In Breast Cancer
OncoPharm
00:00
The Role of ERPR in Cancer Survival
There was no difference in outcomes where women got chemo first or they got chemo after surgery. 10 BID for five years not 20 a day but 10 BID that's what the Tomoxfen dosing was back at that time. In 1988 this is even pre-zofran 10% of people in each arm had six to ten episodes of vomiting in a 24 hour period which certainly doesn't happen in the zofran era now.
Transcript
Play full episode